FORM OF TENDER AND SUPPORT AGREEMENT This TENDER AND SUPPORT AGREEMENT , dated as of May 21, 2023, is entered into by and among Ironwood Pharmaceuticals, Inc., a Delaware. | May 23, 2023
Exclusive License with Asahi Kasei Pharma to develop and commercialize Apraglutide in Japan includes $30 million upfront cash payment, eligibility for up to $170 million in development and commercial. | March 30, 2022